Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Apr;55(8):1069.
doi: 10.1111/apt.16871.

Letter: potential selection bias in the real-world comparison of ustekinumab versus vedolizumab as a second-line treatment for Crohn's disease

Motohiko Adomi  1 , Avik Ray  1
Affiliations
Comment

Letter: potential selection bias in the real-world comparison of ustekinumab versus vedolizumab as a second-line treatment for Crohn's disease

Motohiko Adomi et al. Aliment Pharmacol Ther. 2022 Apr.
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

REFERENCES

    1. Lenti MV, Dolby V, Clark T, et al. A propensity score-matched, real-world comparison of ustekinumab vs vedolizumab as a second-line treatment for Crohn’s disease. The cross Pennine study II. Aliment Pharmacol Ther. 2022;55:856-866.
    1. U.S. FDA. STELARA (ustekinumab) Injection. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/761044Orig1s000T.... Accessed January 23, 2022.
    1. Stürmer T, Wang T, Golightly YM, Keil A, Lund JL, Jonsson FM. Methodological considerations when analysing and interpreting real-world data. Rheumatology (Oxford). 2020;59(1):14-25.
    1. Brookhart MA, Wyss R, Layton JB, Stürmer T. Propensity score methods for confounding control in nonexperimental research. Circ Cardiovasc Qual Outcomes. 2013;6(5):604-11.

MeSH terms

LinkOut - more resources